Gufic BioSciences Quarterly Results for Trading Insights
GUFICBIO • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹17 Cr
QSept 2025
Gufic BioSciences Quarterly Results Key Highlights
- Revenue of ₹239 Cr in Sept 2025 (+16.6% vs Mar 2025, +17.2% vs Sept 2024)
- Net Profit of ₹17 Cr in Sept 2025 (+112.5% vs Mar 2025, -22.7% vs Sept 2024)
- EBITDA of ₹40 Cr in Sept 2025 (+48.1% vs Mar 2025)
- Operating Margin of 16.0% in Sept 2025 (+3.0pp vs Mar 2025)
- Earnings Per Share of ₹1.68 in Sept 2025 (+118.2% vs Mar 2025)
Gufic BioSciences Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 239 | 205 | 225 | 232 | 204 | 16.6% | 17.2% |
| Net Profit (₹ Cr) | 17 | 8 | 13 | 12 | 22 | - | - |
| EBITDA (₹ Cr) | 40 | 27 | 34 | 34 | 39 | - | - |
| EPS (₹) | 1.68 | 0.77 | 1.30 | 1.24 | 2.17 | - | - |
| Operating Margin (%) | 16.0% | 13.0% | 15.0% | 14.0% | 19.0% | - | - |
Gufic BioSciences Share Price Trend Around Quarterly Results
Visualize Gufic BioSciences's 1-year price movement across quarterly results — ideal for logging trades in Gufic BioSciences share price
chart using Tickjournal. All values in ₹.
Related Pages for Gufic BioSciences
Additional stock information and data for GUFICBIO
Revenue Trend (₹ Cr)
Dec 2025
232
Jun 2025
225
Mar 2025
205
Sept 2025
239
Net Profit Trend (₹ Cr)
Dec 2025
12
Jun 2025
13
Mar 2025
8
Sept 2025
17
Operating Margin Trend (%)
Dec 2025
14.0%
Jun 2025
15.0%
Mar 2025
13.0%
Sept 2025
16.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Gufic BioSciences quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1752.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 134.8 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6403.5 | 2,860 | 689 | +7.1% | - | 24.1% | 246.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4369.2 | 3,219 | 591 | +11.3% | - | 18.4% | 249.1 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1351.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.8 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1294.4 | 9,135 | 1,337 | +1.1% | - | 14.6% | 80.0 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores